Dr. Joachim Lupberger began his career in 2002 with a master thesis that he conducted at the Massachusetts Institute of Technology in Cambridge. Between 2003-2007, he undertook his PhD studies under the direction of Prof. D. Krueger, Humboldt University of Berlin and the supervision of Dr. E. Hildt, Robert-Koch Institute, Berlin and University of Freiburg, Germany. During his PhD, Joachim identified a novel bipartite nuclear localization signal in the polymerase of Hepatitis B virus (HBV) that is controlled by host signaling events and developed a novel method for the improvement of hepatitis B virus (HBV) production in vitro. He was awarded his PhD diploma by the Humboldt University Berlin, Germany in 2007. He went on to join the team of Prof. T. Baumert in the Inserm Unit U1110, Strasbourg, France as a post-doctoral fellow in 2007. His research involved the identification and characterization of signaling pathways and virus-host interactions important for HCV entry. Among others, he identified epidermal growth factor receptor (EGFR) as an important regulator of HCV entry and viral leverage to evade the host antiviral response. In 2013, he was awarded a Research associate position (CRCN Inserm) and is pursuing his research in the Inserm Unit U1110.